Come up with a name for your new list and we'll add to it:
BioFocus raised a round of funding on March 13, 2014. Investors include
Charles River Laboratories.
BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capabilities in neurodegenerative diseases, inflammatory diseases and rare a…